🔗 Permalink

Inventor profile of:

Yoseph Shaaltiel

City:

Timrat

Country:

Israel

Published Applications:

Last publication date:

2026-02-19

Top Assignees for applications by Yoseph Shaaltiel

The entities that hold a legal rights for patent applications filed by inventor Shaaltiel Yoseph:

PROTALIX LTD. 17 Carmiel, Israel
HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. 1 Jerusalem, Israel

Recent patent applications by Shaaltiel Yoseph

Yoseph Shaaltiel from Timrat, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-19

US20260049297A1

Chemistry; metallurgy

STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF

#2 | 2025-05-01

US20250134968A1

Human necessities

THERAPEUTIC REGIMEN FOR THE TREATMENT OF FABRY USING STABILIZED ALPHA-GALACTOSIDASE

#3 | 2023-03-09

US20230074255A1

Chemistry; metallurgy

STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF

#4 | 2022-04-07

US20220106578A1

Chemistry; metallurgy

Modified DNase and uses thereof

#5 | 2020-05-21

US20200155654A1

Human necessities

Therapeutic regimen for the treatment of Fabry using stabilized alpha-galactosidase

#6 | 2019-08-22

US20190256832A1

Chemistry; metallurgy

Stabilized alpha-galactosidase and uses thereof

#7 | 2018-11-15

US20180327476A1

Chemistry; metallurgy

Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same

#8 | 2018-10-11

US20180291084A1

Chemistry; metallurgy

CHIMERIC POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME

#9 | 2018-05-31

US20180148703A1

Chemistry; metallurgy

Stabilized α-galactosidase and uses thereof

#10 | 2018-04-26

US20180112201A1

Chemistry; metallurgy

Modified DNase and uses thereof

#11 | 2017-04-13

US20170101633A1

Chemistry; metallurgy

METHOD OF MAINTAINING DISEASE STABILITY IN A SUBJECT HAVING GAUCHER'S DISEASE

#12 | 2016-04-07

US20160095907A1

Human necessities

PLANT CELL CULTURE EXPRESSING HUMAN LYSOSOMAL PROTEINS AND USES THEREOF

#13 | 2016-03-17

US20160075754A1

Chemistry; metallurgy

Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same

#14 | 2016-02-25

US20160053247A1

Chemistry; metallurgy

Stabilized alpha-galactosidase and uses thereof

#15 | 2016-01-21

US20160017021A1

Chemistry; metallurgy

TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME

#16 | 2016-01-21

US20160017020A1

Chemistry; metallurgy

CHIMERIC POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME

#17 | 2016-01-21

US20160017019A1

Chemistry; metallurgy

Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy

#18 | 2015-01-22

US20150024050A1

Human necessities

Dry powder formulations of dNase I

#19 | 2015-01-22

US20150023929A1

Human necessities

ORAL UNIT DOSAGE FORMS AND USES OF SAME FOR THE TREATMENT OF GAUCHER DISEASE

#20 | 2015-01-08

US20150010617A1

Human necessities

Inhalable liquid formulations of DNase I

#21 | 2015-01-08

US20150010527A1

Human necessities

DNASE I POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, METHODS OF PRODUCING DNASE I AND USES THEREOF IN THERAPY

#22 | 2014-09-18

US20140271577A1

Human necessities

Plant cell culture expressing human lysosomal proteins and uses thereof

InventorID:

1028751 ⎘